Education
About Us
Working with TipRanks
Follow Us
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
14C Rpt193
Healthy Male Subjects
Phase I
Completed
Study of RPT193 in Healthy Adult Male Subjects
Oct 04, 2023
―
Rpt193
Asthma
Phase II
Terminated
Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
Jun 26, 2023
―
Rpt193
Atopic Dermatitis
Phase II
Terminated
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
May 26, 2022
―
Ipilimumab, Flx475
Advanced Melanoma
Phase II
Terminated
FLX475 in Combination With Ipilimumab in Advanced Melanoma
May 12, 2021
―
Rpt193
Atopic Dermatitis
Phase I
Completed
A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
Feb 13, 2020
―
Flx475, Pembrolizumab (Keytruda®)
Advanced Cancer
Phase I/II
Completed
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Sep 14, 2018
―
Flx925
Acute Myeloid Leukemia
Phase I
Terminated
First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Jan 05, 2015
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does RAPT Therapeutics (RAPT) have in its pipeline
RAPT is currently developing the following drugs: 14C Rpt193, Rpt193, Rpt193. These drug candidates are in various stages of clinical development as the company works toward FDA approval.